Jack West, MD of Swedish Cancer Institute explains how anti-PD-L1 and PD-1 therapies are being incorporated into lung cancer treatment algorithms at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Incorporating anti-PD-L1/PD-1 therapy into lung cancer treatment
